These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 6314952

  • 1. Herpes simplex acyclovir-resistant mutant in experimental keratouveitis.
    Boisjoly HM, Park NH, Pavan-Langston D, De Clercq E.
    Arch Ophthalmol; 1983 Nov; 101(11):1782-6. PubMed ID: 6314952
    [Abstract] [Full Text] [Related]

  • 2. The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs.
    Field H, McMillan A, Darby G.
    J Infect Dis; 1981 Feb; 143(2):281-5. PubMed ID: 6260876
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil against acute herpes simplex virus keratitis and the establishment of latency: comparison with acyclovir and bromovinyldeoxyuridine.
    Rajcáni J, Reefschläger J.
    Acta Virol; 1987 Aug; 31(4):329-39. PubMed ID: 2892382
    [Abstract] [Full Text] [Related]

  • 4. Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease.
    Charles SJ, Gray JJ.
    Br J Ophthalmol; 1990 May; 74(5):286-8. PubMed ID: 2162190
    [Abstract] [Full Text] [Related]

  • 5. Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir.
    Field HJ, Neden J.
    Antiviral Res; 1982 Oct; 2(5):243-54. PubMed ID: 6295272
    [Abstract] [Full Text] [Related]

  • 6. Chemotherapy of herpetic keratitis induced by acyclovir-resistant strains of herpes simplex virus type 1.
    O'Brien WJ, Taylor JL.
    Am J Med; 1982 Jul 20; 73(1A):294-9. PubMed ID: 6285720
    [Abstract] [Full Text] [Related]

  • 7. Dendritic keratitis caused by an acyclovir-resistant herpes simplex virus with frameshift mutation.
    Zhang W, Suzuki T, Shiraishi A, Shimamura I, Inoue Y, Ohashi Y.
    Cornea; 2007 Jan 20; 26(1):105-6. PubMed ID: 17198024
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine).
    Smith KO, Kennell WL, Poirier RH, Lynd FT.
    Antimicrob Agents Chemother; 1980 Feb 20; 17(2):144-50. PubMed ID: 6247967
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Wilber BA, Docherty JJ.
    J Gen Virol; 1994 Jul 20; 75 ( Pt 7)():1743-7. PubMed ID: 8021603
    [Abstract] [Full Text] [Related]

  • 10. [Resistance of herpes simplex viruses to antiviral drugs].
    Scieux C, Bianchi A.
    Pathol Biol (Paris); 1993 Feb 20; 41(2):172-7. PubMed ID: 8392160
    [Abstract] [Full Text] [Related]

  • 11. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
    Coen DM, Fleming HE, Leslie LK, Retondo MJ.
    J Virol; 1985 Feb 20; 53(2):477-88. PubMed ID: 2982032
    [Abstract] [Full Text] [Related]

  • 12. Problems associated with the use of (E)-5-(2-bromovinyl)-2'-deoxyuridine for typing herpes simplex virus.
    Swierkosz EM, Arens MQ, Rivetna KA.
    J Clin Microbiol; 1985 Mar 20; 21(3):459-61. PubMed ID: 2984249
    [Abstract] [Full Text] [Related]

  • 13. Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation.
    Ljungman P, Ellis MN, Hackman RC, Shepp DH, Meyers JD.
    J Infect Dis; 1990 Jul 20; 162(1):244-8. PubMed ID: 2162368
    [Abstract] [Full Text] [Related]

  • 14. Oral antiviral drugs in experimental herpes simplex keratitis.
    Kaufman HE, Varnell ED, Centifanto-Fitzgerald YM, De Clercq E, Kissling GE.
    Antimicrob Agents Chemother; 1983 Dec 20; 24(6):888-91. PubMed ID: 6318664
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
    Coen DM, Irmiere AF, Jacobson JG, Kerns KM.
    Virology; 1989 Feb 20; 168(2):221-31. PubMed ID: 2536980
    [Abstract] [Full Text] [Related]

  • 17. Properties of a 9-(2-phosphonylmethoxyethyl)adenine (PMEA)-resistant herpes simplex virus type 1 virus mutant.
    Vonka V, Anisimová E, Cerný J, Holý A, Rosenberg I, Votruba I.
    Antiviral Res; 1990 Aug 20; 14(2):117-21. PubMed ID: 2177316
    [Abstract] [Full Text] [Related]

  • 18. Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir.
    McLaren C, Chen MS, Ghazzouli I, Saral R, Burns WH.
    Antimicrob Agents Chemother; 1985 Dec 20; 28(6):740-4. PubMed ID: 3002245
    [Abstract] [Full Text] [Related]

  • 19. Acyclovir--a promising antiviral agent: a review of the preclinical and clinical data in ocular herpes simplex management.
    Koliopoulos J.
    Ann Ophthalmol; 1984 Jan 20; 16(1):19-24. PubMed ID: 6322661
    [Abstract] [Full Text] [Related]

  • 20. Acyclovir resistance in herpes simplex virus type 1: biochemical and functional studies on the thymidine kinase of the highly resistant R100 strain.
    Palú G, Bevilacqua F, Biasolo MA, Parolin C, Tognon M, Romanelli MG, Meloni GA.
    Virus Res; 1989 Aug 20; 13(4):303-18. PubMed ID: 2554611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.